Selected Publications

Hubbeling HG, Silverman EA, Michaud L, Alarcon Tomas A, Shouval R, Flynn J, Devlin S, Wijetunga NA, Tringale KT, Batlevi C, Dahi P, Giralt S, Lin R, Park J, Scordo M, Sauter C, Shah G, Hajj C, Salles G, Schoder H, Palomba ML, Perales MA, Joachim Y, Imber BS.: Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Therapy 29(4): 259.e1-259.e10, Apr 2023.

Miao E, Eichholz JE, Lebow ES, Flynn J, Zhang Z, Walch H, Hubbeling HG, Beal K, Moss NS, Yu K, Yang JT, Meng A, Kelly DW, Gomez DR, Rimner A, Schultz N, Drilon A, Imber BS, Pike LRG.: Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib. Lung Cancer 178: 57-65, Apr 2023.

Hubbeling HG, Choudhury N, Flynn J, Zhang Z, Falcon C, Rusch VW, Park BJ, Ziv E, Shaverdian N, Gelblum DY, Shepherd AF, Simone CB, Wu AJ, Gomez DR, Drilon A, Rimner A: Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ ROS1/ RET-Rearranged Lung Cancers. JCO Precision Oncology 6: e2200024, Oct 2022.

Hubbeling HG, Silverman EA, Michaud L, Flynn J, Devlin S, Wijetunga NA, Alarcon Tomas A, Shouval R, Palomba ML, Batlevi C, Dahi P, Park J, Scordo M, Sauter C, Shah G, Schoder H, Perales MA, Hajj C, Joachim Y, Imber, BS: Patterns of Relapse and Risk Reduction Following Tumor Debulking by Bridging Radiotherapy Prior to Chimeric Antigen Receptor T Cell Therapy in Non-Hodgkin Lymphoma. 62nd Annual American Society for Radiation Oncology Meeting, San Antonio, TX Oct 2022 Notes: Oral Presentation.

Tringale KR, Behroze VA, Hubbeling HG, Hajj C, Yahalom J, Grommes C, Imber BS: Outcomes and Failure Patterns for >500 Patients Treated for Primary CNS Lymphoma (PCNSL). 62nd Annual American Society for Radiation Oncology Meeting, San Antonio, TX Oct 2022 Notes: Oral Presentation.

Hubbeling HG, Silverman EA, Alarcon Tomas A, Tringale KR, Wijetunga NA, Hajj C, Mailankody S, Batlevi C, Dahi P, Giralt S, Lin R, Park J, Scordo M, Sauter C, Shah G, Perales MA, Palomba ML, Shouval R, Joachim Y, Imber BS.: Radiotherapy for Relapse after Chimeric Antigen Receptor T Cell Therapy in Hematologic Malignancies. 62nd Annual American Society for Radiation Oncology Meeting, San Antonio, TX October 2022 Notes: Oral Presentation.

Tringale KR, Hubbeling HG, Chino F, Hajj C, Yahalom J, Imber BS: Trends in Use of and Medicare Spending on Short-Course Radiotherapy for Lymphomas From 2015 to 2019. JAMA Health Forum 3(7): e221815, Jul 2022.

Ma J, Daou R, Bou Eid J, Lee J, Fregonese B, El-Khoury J, Wijetunga NA, Hubbeling HG, Tringale KR, Lebow ES, Imber BS, Yahalom J, Hajj C: The Role of Radiation Therapy in the Treatment of Primary Hepatic Lymphomas. European Society of Radiation Oncology Annual Meeting 2022, Copenhagen, Denmark May 2022 Notes: Oral Presentation.

Hubbeling HG, Imber BS, Wijetunga NA, Tringale KR, Hajj C, Yahalom J: Irradiating the Spleen for non-Hodgkin Lymphoma: Efficacy and Tolerance. European Society of Radiation Oncology Annual Meeting 2022, Copenhagen, Denmark May 2022 Notes: Poster Presentation.

Tringale KR, Grommes C, Behroze VA, Hubbeling HG, Wijetunga NA, Hajj C, Yahalom J, Imber BS: Patterns of Failure in Primary CNS Lymphoma: the MSKCC Experience from 2004-2018. European Society of Radiation Oncology Annual Meeting 2022, Copenhagen, Denmark May 2022 Notes: Poster Presentation.